Un-Audited Financial Results for the Quarter ended December 31, 2025, along with draft Limited Review Report pursuant to Regulation 33 of the Securities Exchange and Board of India (Listing ....
Awaiting price reaction for this filing.
Garodia Chemicals reported zero revenue from operations for Q3 FY26 (Oct-Dec 2025) and the nine-month period, marking a complete halt in business activity. The company posted a small loss of ₹2.54 lakhs in Q3 FY26, against a profit of ₹402.49 lakhs in the previous quarter (Q2 FY26), which was entirely driven by a one-time other income of ₹405.88 lakhs from the settlement of loans owed by promoters/directors (Mr. Mahesh Garodia, Mr. Nishant Garodia, and Garodia Sons Pvt Ltd) under a Base Resolution Plan approved by NCLT Mumbai. The auditor flagged that the accounts are no longer prepared on a going-concern basis as management has decided to cease the company's business, and also noted unconfirmed debtor/creditor balances and insufficient documentation for contingent liabilities. EPS for the quarter stood at (₹0.04), sharply down from ₹5.59 in Q2 FY26.
This is a major red flag for shareholders — the company has effectively shut down operations, is not a going concern, and its recent profit came only from one-time loan settlements with related parties rather than any business activity. The stock is likely to face significant pressure and remains a high-risk, possibly delisting-prone situation pending clarity on NCLT resolution outcomes.